http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101471287-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-304 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
filingDate | 2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101471287-B1 |
titleOfInvention | Composition containing peptides from spirulina maxima for prevention or treatment of Allergic disease |
abstract | The present invention relates to an anti-allergic activity of a hydrolyzate obtained by hydrolyzing at least one enzyme selected from the group consisting of trypsin,? -Chymotrypsin and pepsin, or a peptide obtained by purifying the hydrolyzate. The hydrolyzate derived from Spirulina maxima according to the present invention or the peptide isolated and purified thereof inhibits the degranulation activity of mast cells and inhibits the expression of Fc? RI on the surface of mast cells to thereby provide an effective anti-allergic activity to maximize the prevention or therapeutic effect of allergy-related diseases It will be possible. In addition, the hydrolyzate derived from Spirulina maxima or the peptide isolated and purified therefrom is a naturally derived substance, and can be used as a health functional food since it is free from toxicity and side effects and can be used safely for a long period of time. |
priorityDate | 2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 429.